CUV 0.68% $14.64 clinuvel pharmaceuticals limited

Ann: Change of Director's Interest Notice, page-18

  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797
    People don't like the truth.

    The only thing CUV has achieved is getting a 40 year old patent-expired drug approved for a rare disease. It took them a decade to achieve that relatively simple task, Yet posters spam the forum non-stop with rubbish about a series blockbuster drugs that are 'certainties' to be approved in the near future.The reality is more like 3-5 years with a 5-10% chance of success.

    If the prospects are so good why are directors selling their shares? It defies logic.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.